Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc.

AMEX:ARMP

Overview | Financials
Company Name Armata Pharmaceuticals, Inc.
Symbol ARMP
Currency USD
Price 2.22
Market Cap 80,202,606
Dividend Yield 0%
52-week-range 0.83 - 5.26
Industry Biotechnology
Sector Healthcare
CEO Dr. Deborah L. Birx M.D.
Website https://www.armatapharma.com

An error occurred while fetching data.

About Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment

Related Stocks

Matinas BioPharma Holdings, Inc. logo

Matinas BioPharma Holdings, Inc.

MTNB

0.235 USD

VolitionRx Limited logo

VolitionRx Limited

VNRX

0.748 USD

Stereotaxis, Inc. logo

Stereotaxis, Inc.

STXS

1.56 USD

CEL-SCI Corporation logo

CEL-SCI Corporation

CVM

2.18 USD

Retractable Technologies, Inc. logo

Retractable Technologies, Inc.

RVP

1.08 USD

Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc.

ATNM

4.49 USD

InfuSystem Holdings, Inc. logo

InfuSystem Holdings, Inc.

INFU

9.29 USD

Cybin Inc. logo

Cybin Inc.

CYBN

0.45 USD

Electromed, Inc. logo

Electromed, Inc.

ELMD

10.5 USD

Lineage Cell Therapeutics, Inc. logo

Lineage Cell Therapeutics, Inc.

LCTX

0.95 USD

Financials

Numbers are in millions USD

Numbers are in millions USD